Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...

Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...

Localized pustular psoriasis is a term that refers to a limited area of small pus-filled blisters on your skin, typically on your hands or feet. It is distinct from generalized pustular psoriasis (GPP ...

Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...

Investing.com -- Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock jumped 5.1% Monday after the company announced it submitted a Biologics License Application (BLA) to the FDA for imsidolimab, a treatment ...

PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis: San Francisco Monday, December 1, 202 ...

SAN FRANCISCO and SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

The most common concern of chemotherapy patients is that their skin is not the same as before", "A handful of hair is falling out."It's hard to walk because my nails hurt" It's a story of the same ...